Citations

Clear

4207 citation(s) found for "Chen, Bo".

Combining post-mortem and neuroimaging measures of brain amyloidosis to accelerate genomic discovery
Wang, Ting‐Chen , Ali, Muhammad, Wu, Yiyang , Mormino, Elizabeth, Buckley, Rachel F. , Saykin, Andrew J, Jager, Philip L. De , Schneider, Julie A, Vardarajan, Badri, Mayeux, Richard, Kunkle, Brian W, Keene, C Dirk, Seshadri, S, Sperling, Reisa A, Kamboh, M Ilyas, Jagust, William J. , Schellenberg, Gerard D, Huentelman, MJ, Hamilton-Nelson, Kara, Pericak-Vance, Margaret A, Haines, Jonathan L, Montine, Thomas J, Beecham, Gary, Archer, Derek , Wu, Yiyang , Buckley, Rachel F , De Jager, Philip L , Bennett, David A. , Barnes, Lisa L , Bush, William S , Vemuri, Prashanthi , Ramanan, Vijay K , Harrison, Theresa M , Jagust, William J , Laws, Simon M , Below, Jennifer E , Cruchaga, Carlos , Seto, Mabel , Dumitrescu, Logan , Archer, Derek B. , Ali, Muhammad , Mormino, Elizabeth C. , Lee, Annie , Saykin, Andrew J. , Schneider, Julie A. , Bennett, David A. , Barnes, Lisa L. , Vardarajan, Badri Narayan , Mayeux, Richard , Kunkle, Brian W. , Bush, William S. , Keene, C Dirk, Sperling, Reisa Anne , Vemuri, Prashanthi , Ramanan, Vijay K. , Kamboh, M. Ilyas , Harrison, Theresa M. , Schellenberg, Gerard D. , Hamilton‐Nelson, Kara L. , Pericak‐Vance, Margaret A. , Goate, Alison , Haines, Jonathan L. , Montine, Thomas J. , Beecham, Gary W. , Hohman, Timothy J. , Dumitrescu, Logan

Mayo Clinic

Brain | June 23, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1093/brain/awag216 | PMID 42334898 Get It

Abstract Histopathological assessment has served as the gold standard for diagnosing Alzheimer’s disease (AD). Emerging technological advancements, including the development of amyloid positron emission tomography (PET), have enabled early detection of amyloid pathology, one of the neuropathological hallmarks of AD. Genome-wide association study (GWAS) across cohorts of aging and AD, leveraging different measurements of amyloid burden, may facilitate the identification of novel genetic variants that drive the earliest neuropathological changes in AD. This study presents the largest GWAS of brain amyloidosis to date, leveraging amyloid β (Aβ) measured by in vivo amyloid PET and postmortem histopathology from 13,555 individuals of European ancestry. Amyloid positivity was defined as moderate or frequent neuritic plaques according to the Consortium to Establish a Registry for Alzheimer’s Disease (CERAD) staging scores for each postmortem cohort. A Gaussian mixture model (GMM) was applied to each amyloid PET cohort to identify the cohort and tracer-specific cut-offs that differentiate amyloid positive and negative populations. In silico and ex vivo analyses further characterized implicated loci, including interrogating the association between bulk and single-nucleus gene expression profiles and AD-related traits. Genetic covariance analysis assessed the extent amyloid PET and postmortem measures reflect the shared genetic architecture of brain amyloidosis. Our combined amyloidosis GWAS identified three established AD risk loci: BIN1 (rs6733839, OR = 1.20, 95% CI 1.14-1.26, P = 1.32 × 10−11), CR1 (rs4844610, OR = 1.24, 95% CI = 1.16-1.32, P = 4.21 × 10−10), APOE (rs429358, OR = 4.01, 95% CI = 3.66-4.38, P = 4.54 × 10−201), and a newly identified brain amyloidosis-associated variant on chromosome 17 (rs35635959, OR = 1.18, 95% CI = 1.12-1.25, P = 1.47 × 10−8). SuSiE fine-mapping identified a single credible set of 15 putative causal variants with rs35635959 as the lead variant. Subsequent eQTL and SuSiE-based colocalization analyses prioritized rs35635959 as a strong eQTL for TUBG2, encoding tubulin gamma 2, which is involved in microtubule organization and synaptic plasticity. Further cell-type-specific characterization of this gene in neurons from dorsolateral prefrontal cortex tissue indicated that decreased TUBG2 expression was associated with increased Aβ burden and AD case status (PFDR < 0.045). Furthermore, our study is the first to report a modest genetic covariance (covariance=0.17, P < 6.54 × 10−8) between the genetic architecture of amyloid burden captured by different modalities. While APOE showed a strong association with both amyloid endophenotypes, the observed genetic covariance was not substantially attenuated after excluding variants within the APOE region (covariance=0.16, P < 1.32 × 10−7). Our results highlight the benefits of leveraging compatible, harmonized AD endophenotypes to increase power to uncover new molecular insights into the etiology of AD neuropathology. Wang et al. present the largest GWAS of brain amyloidosis to date, analysing 13,555 individuals using amyloid PET and postmortem Aβ measures. They identify a novel amyloidosis-associated variant on chromosome 17, demonstrate genetic covariance between modalities, and highlight complex traits sharing genetic architecture with Aβ burden.
P257 Efficacy and safety up to 3 years of risankizumab in moderately to severely active ulcerative colitis patients: COMMAND interim results
Atreya, Raja, Louis, Edouard, Loftus, Edward V, Rubin, David T, Dubinsky, Marla C., Hisamatsu, T, Kalabic, Jasmina , Méndez, Paloma, Chen, S H, Shah, Saajan, Morisset, Pierre, Duan, W Rachel, Coll, Christina, Panaccione, Remo, Atreya, Raja Narayana , Rubin, David T. , Hisamatsu, Tadakazu, Mendez, Paloma, Morisset, Pierre, Duan, W Rachel, Panaccione, Remo

Mayo Clinic

E-Posters | June 23, 2026 | Volume: No volume available | Issue: No issue available | Pages: A240.2-A241

10.1136/gutjnl-2026-bsg.373 Get It

P171 Efficacy and safety of icotrokinra, a targeted oral peptide that blocks il-23 receptor activation, in ulcerative colitis: results from ANTHEM-UC
Limdi, Jimmy, Jairath, Vipul, Siegmund, Britta, Surace, Lindsey, Erondu, Ngozi, Chen, Minhu, Chachu, Karen, Louis, Edouard, Matsuoka, Katsuyoshi, Houck, Nicole, Frustaci, Mary Ellen, Zhan, Joyce, Rydzewska, G, VLoftus, Edward, Abreu, M T, Jairath, Vipul , Siegmund, Britta, Erondu, Ngozi, Chachu, Karen A., Matsuoka, Katsuyoshi , Arthur, Edmund, Frustaci, Mary Ellen, Rydzewska-Wyszkowska, Grażyna

Mayo Clinic

E-Posters | June 23, 2026 | Volume: No volume available | Issue: No issue available | Pages: A188-A188

10.1136/gutjnl-2026-bsg.299 Get It

O60 Icotrokinra, a targeted oral peptide that blocks IL-23 receptor activation, in moderate-to-severe ulcerative colitis: week 12 results from ANTHEM-UC
Limdi, Jimmy, Abreu, M T, Siegmund, Britta, Surace, Lindsey, Erondu, Ngozi, Chen, Minhu, Chachu, Karen, Louis, Edouard, Matsuoka, Katsuyoshi, Houck, Nicole, Frustaci, Mary Ellen, Zou, Bin, Rydzewska, G, Loftus, Edward V, Jairath, Vipul, Siegmund, Britta, Erondu, Ngozi, Chachu, Karen A., Matsuoka, Katsuyoshi , Arthur, Edmund, Frustaci, Mary Ellen, Zou, Bin , Rydzewska-Wyszkowska, Grażyna , Loftus, Edward V , Jairath, Vipul

Mayo Clinic

Oral Abstracts | June 23, 2026 | Volume: No volume available | Issue: No issue available | Pages: A38-A39

10.1136/gutjnl-2026-bsg.59 Get It

An Integrated muti-omics cell atlas of the human trabecular meshwork and ciliary body
Jian, Jinjing , Bao, Xuan , Zheng, Y , Shao, Jianming , Yang, Tingting , Yaman, Ismail, Li, Jean , Chen, Han, Tolman, Nicholas, Sheridan, Carl, Zode, Gulab S., John, Simon W. M. , Stout, J Timothy, Stamer, Dan, Li, Yumei, Li, Jin , Shao, Jianming , Liu, Yutao , John, Simon Wm , Chen, Rui , Wang, Yi-Xiang , Tolman, Nicholas G. , Scheuermann, Richard H. , Zheng, Jie , Sheridan, Carl , Liu, Yutao , Du, Yiqin , Balasubramanian, Revathi , Zode, Gulab , Stout, J. Timothy, Li, Yumei

Mayo Clinic

No container title available | June 23, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.64898/2026.06.17.732980 | PMID 42395492 Get It

Abstract The trabecular meshwork (TM) and ciliary body (CB) regulate aqueous humor dynamics and intraocular pressure (IOP), and TM/Schlemm’s canal (SC) dysfunction underlies glaucoma. Here, we present a spatially resolved multi-omics atlas of human TM and CB, integrating snRNA-seq, scRNA-seq, and snATAC-seq from over one million cells and nuclei across 112 donors with Xenium spatial transcriptomics. We identified 9 major cell classes and 21 cell types, revealing heterogeneity, including undercharacterized fibroblast and epithelial subpopulations. Spatial mapping supported TM fibroblast zonation and CB epithelial organization. Regulatory analyses identified cell type–specific programs, including OTX/PAX networks in CB epithelium and SMAD3/TGF-β signaling in fibroblasts. Integration with glaucoma loci showed enrichment of non-coding variants in regulatory elements associated with POAG and PACG. Age- and ancestry-associated remodeling revealed divergent fibroblast aging with increased PIEZO1 , suggesting impaired outflow and elevated IOP. Together, this high-resolution atlas links cellular, regulatory, and genetic variation to anterior segment function and glaucoma susceptibility.
A3-04 Pulmonary Presentation of Systemic Inflammation: Autoinflammatory Disease Masquerading as Malignancy
Reeve, M, Chen, J, Wengler, J, Azar, J, Bride, N Mc, Gotway, M B, Sakata, K, Azadeh, N, Azar, Jehad , Azadeh, Natalya

Mayo Clinic

American Journal of Respiratory and Critical Care Medicine | June 22, 2026 | Volume: 212 | Issue: Supplement_2 | Pages: No page available

10.1093/ajrccm/aamag286.004 Get It

Abstract Autoinflammatory syndromes are increasingly recognized as heterogeneous disorders of innate immune dysregulation, often overlapping in clinical and genetic features. Although pulmonary manifestations are uncommon, several autoinflammatory conditions such as VEXAS syndrome, juvenile rheumatoid arthritis, adult-onset Still’s disease, and Familial Mediterranean Fever can produce inflammatory pulmonary nodules that mimic metastatic malignancy. Recognition of these presentations is critical, as they can respond dramatically to immunosuppressive therapy once the correct diagnosis is established. We describe a diagnostically challenging case of a young adult male initially suspected to have metastatic lung cancer, whose evaluation ultimately suggested a previously uncharacterized autoinflammatory process. We present a 26-year-old previously healthy male with progressive dry cough, exertional dyspnea, diffuse myalgias, small joint arthritis involving the fingers, wrists, and ankles, tendonitis, a Gottron-like rash on the hands and lower extremities, low-grade fevers, and occasional bloody stools. Initial external workup revealed a right infrahilar mass, right lower lobe pleural thickening, small pleural effusion, and mediastinal and hilar lymphadenopathy on CT chest, with corresponding PET activity. Initially suspected to have metastatic lung cancer, he was informed his prognosis was poor. However, transbronchial, EBUS, and mediastinal lymph node biopsies showed only active inflammation without malignancy. On presentation to our facility, a broad differential was pursued, with suspicion for an autoinflammatory or autoimmune etiology. Pulmonary function testing was normal. Laboratory evaluation revealed ESR >100, elevated CRP, positive ANA (1:160), negative HLA-B27, normal ferritin, and negative S100 staining. Cytokine analysis showed elevated TNF, IL-6, MCP-1, IL-2, and IL-18. Targeted variant testing identified a UBA1 gene variant, c.123G>T p.(M41L), with low-level mosaicism (0.004%), and a heterozygous MEFV mutation. Although his ethnicity made Familial Mediterranean Fever unlikely, these findings raised the possibility of overlapping somatic and germline contributions to innate immune activation. He was treated empirically with immunosuppression for a presumed multisystem inflammatory disorder, resulting in resolution of symptoms and marked radiologic improvement. This case highlights the expanding spectrum of adult-onset autoinflammatory diseases that may present with pulmonary findings mimicking malignancy. The coexistence of low-level UBA1 mosaicism and MEFV mutation suggests a potential interaction between somatic and inherited variants in triggering inflammation. Similar to the recent discovery of VEXAS syndrome, this case may represent a novel subtype of autoinflammatory disease. Continued genomic and immunologic investigation is warranted, as timely recognition and immunosuppressive therapy can lead to dramatic recovery. This abstract is funded by: None
Artificial Intelligence Models for Classifying Wrist Ligament Injuries Using Synthetically-Generated Joint Proximity Maps from Finite Element Models
Chen, Hsuan-Yu, Camp, Jon, Thoreson, Andrew R. , Leng, Shuai , Holmes, David R. , Kakar, Sanjeev , An, Kai‐Nan , Zhao, Kristin D. , Andreassen, Thor E. , Yu Chen, Hsuan, Trentadue, Taylor P , Thoreson, Andrew R , Leng, Shuai , Holmes, David R , Kakar, Sanjeev , An, Kai-Nan , Trentadue, Taylor P , Andreassen, Thor E , Camp, Jon J. , Trentadue, Taylor P.

Mayo Clinic

No container title available | June 22, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.64898/2026.06.17.733030 | PMID 42367846 Get It

Abstract Background/Purpose Diagnosing wrist ligament injuries is challenging; early detection and treatment are important to prevent osteoarthritis progression. Interosseous proximity maps, a proxy measure for joint space, can be generated from volumetric imaging data and may provide important information about wrist health. Artificial intelligence (AI) could enhance accuracy of noninvasive diagnosis based on imaging-derived metrics. This work demonstrates feasibility of AI training using synthetic proximity map data generated from finite element models (FEMs). Methods Personalized wrist FEMs for two asymptomatic participants were created from four-dimensional computed tomography-derived anatomic and kinematic data. Monte Carlo sampling varied 22 ligament material properties and simulated 7,500 unique injury scenarios generating 9,000,000 labeled red, green, and blue (RGB) images of interosseous proximity vector fields from FEM-derived motions. Images were associated with 17 descriptive metrics, including gross wrist angles and bone surface pairs, and used to develop mixed-input convolutional neural networks (CNNs). Model performance was evaluated for identifying specific ligament injuries. Results Average area under receiver operating characteristic curve (AUROC) for CNNs was 0.757 across all injury types and kinematics. In a subset with clinically-relevant functional angles, the average AUROC was 0.824. Best-performing individual ligament AUROCs ranged from 0.807 to 0.999. Sensitivities and specificities exceeded 0.99 for some ligament injury simulations under specific wrist angles and bone surface pairs. Conclusion This study demonstrates the feasibility of using synthetic data from FEMs to train AI models for classifying wrist ligament injuries. Proximity-based RGB images may be a relevant biomarker of ligamentous injury.
Influence of corneal endothelial cell density after penetrating keratoplasty on contact lens induced corneal swelling
Szczotka‐Flynn, Loretta , Schornack, Muriel , Benetz, Beth Ann , Chen, Zhengxi, Takhar, Jaskirat S. , Nguyen, Tracy, Tt, McMahon, Michaud, Langis , Chen, Zhengxi , Takhar, Jaskirat , Sindt, Christine , Hartman, Holly , Michaud, Langis , Schornack, Muriel , Szczotka‐Flynn, Loretta

Mayo Clinic

Optometry and Vision Science | June 21, 2026 | Volume: 103 | Issue: 6 | Pages: No page available

10.1002/ovs2.70080 | PMID 42323276 Get It

ABSTRACT Purpose Substantial endothelial cell loss (∼80%) occurs after keratoplasty. Corneal rigid and scleral lenses are frequently prescribed to manage irregular astigmatism and high refractive error, but lens wear may contribute to hypoxic stress. The relationship between various lens wear and corneal stress after penetrating keratoplasty remains unclear. This study characterizes cell density distribution in post‐keratoplasty corneas and evaluates its influence on swelling during lens wear. Methods Participants ≥5 years post‐surgery, with or without habitual lens wear, were enrolled. Specular microscopy measured endothelial cell density in central, superior, inferior, superotemporal, and superonasal corneal quadrants (@3 mm). Baseline corneal thickness maps (>2 h after waking without lens wear) were acquired using Scheimpflug imaging (Pentacam). Wearers applied habitual lenses and all participants returned 6–8 h later for imaging. Nonparametric tests assessed cell density variation by quadrant and lens designs. Linear mixed models evaluated associations between endothelial parameters and corneal swelling while accounting for within‐subject correlation, repeated measures, lens type, location, and interactions. Results Twenty‐five participants (31 eyes) from three centers were included; 90% had keratoconus preoperatively. Four wore large‐diameter scleral lenses (13%), nine wore small‐diameter scleral lenses (29%), 12 wore corneal rigid lenses (39%), and six did not wear lenses (19%). Cell density across quadrants averaged 780 ± 240 cells/mm 2 . Central thickness decreased slightly in non‐lens‐wearing eyes (−0.3%) but increased in lens‐wearing eyes (1.9% ± 3.1%). Central cell density showed a weak negative correlation with swelling ( r = −0.39, p = 0.03). Compared with non‐lens wearers, corneal rigid ( p = 0.02) and large diameter scleral lenses ( p = 0.05) generated greater swelling; smaller diameter scleral lenses did not. Conclusions Although all eyes fitted with various lens designs were clear, lower central cell density correlated with increased swelling during lens wear, except when smaller diameter scleral lenses were worn. Clinically, however, cell density does not seem to be a robust predictor of corneal swelling induced by lens wear post‐keratoplasty.
Mortality in Castration Resistant Prostate Cancer Patients With and Without Pre‐Existing Cardiovascular Disease Receiving Oral Androgen Receptor Pathway Inhibitors
Chen, R, Master, Viraj, Mi, Lanyu , James, Sarah E., Moore, Cassandra, Bryce, Alan H., Tilburt, Jon C., Riaz, Irbaz B, Naqvi, Syed Arsalan Ahmed , Afzal, Umar, Cobran, Ewan K. , Asiri, Ibrahim M. , Cobran, Ewan K , Bryce, Alan H. , Tilburt, Jon C. , Beach, Steven R. H.

Mayo Clinic

Pharmacoepidemiology and Drug Safety | June 20, 2026 | Volume: 35 | Issue: 7 | Pages: No page available

10.1002/pds.70405 | PMID 42322109 Get It

ABSTRACT Background Men with castration‐resistant prostate cancer (CRPC) who have a pre‐existing history of cardiovascular disease (CVD) or other comorbidities are often excluded from clinical trials involving oral androgen receptor pathway inhibitors (ARPi). In this study, we compared all‐cause and prostate cancer‐specific mortality among CRPC patients, with and without a pre‐existing history of CVD, receiving ARPi compared to chemotherapy. Methods Men with CRPC were identified using the Surveillance, Epidemiology, and End Results‐Medicare Linked Database from 2004 to 2015. Patients were grouped into two analytical cohorts by drug use. Inverse probability treatment weights (IPTW)‐adjusted Cox models and Fine‐Gray subdistribution hazards models were used to evaluate associations between ARPi and chemotherapy, and between ENZ and AA for all‐cause mortality and cancer‐specific mortality separately. Results The study cohort included 1438 men with CRPC. Nearly 54.4% of patients had a pre‐existing history of CVD. Patients with a pre‐existing history of CVD had a higher incidence of all‐cause and prostate cancer‐specific mortality compared to patients without a history of CVD (all‐cause mortality: 69.7% vs. 59.3%, prostate cancer‐specific mortality: 56.0% vs. 49.5%, respectively). In the pre‐existing history of CVD cohort, the IPTW‐adjusted Cox model showed a significantly lower all‐cause mortality in patients who received APRi, enzalutamide, and abiraterone, versus chemotherapy (IPTW‐adjusted hazard ratio [AHR], 0.56; 95% Confidence Interval [CI], 0.48–0.64; p ‐value < 0.001). Further, the IPTW‐adjusted competing risk model showed significantly lower prostate cancer‐specific mortality in patients who received ARPi compared with those who received chemotherapy (IPTW‐AHR, 0.48; 95% CI, 0.41 to 0.57; p ‐value < 0.001). In the without pre‐existing history of CVD cohort, the adjusted Cox model showed significantly lower all‐cause mortality in patients who received APRi than those who received chemotherapy (IPTW‐AHR, 0.49; 95% CI, 0.41–0.60; p ‐value < 0.001). Whereas the IPTW‐adjusted competing risk model showed significantly lower prostate cancer‐specific mortality in patients who received ARPi compared with those who received chemotherapy (IPTW‐AHR, 0.52; 95% CI, 0.42–0.64; p ‐value < 0.001). Conclusion In this population‐based cohort of older men with castration‐resistant prostate cancer, treatment with oral androgen receptor pathway inhibitors was associated with lower estimated risks of all‐cause and prostate cancer–specific mortality compared with chemotherapy in patients with and without pre‐existing CVD. These findings add real‐world comparative effectiveness evidence for patient populations not well represented in randomized clinical trials; however, given the observational design and limitations of administrative data, residual confounding and unmeasured clinical differences may have influenced the results.
In Reply:
Chen, Valerie , Theiler, Regan N.

Mayo Clinic

Obstetrics & Gynecology | June 18, 2026 | Volume: 148 | Issue: 1 | Pages: e61-e61

10.1097/aog.0000000000006317 | PMID 42314201 Get It